Dallas, TX 3/28/2012 10:01:33 PM
News / Finance

MSLP, GOSY, VRML are included in our Top Penny Stock Gainers

MSLP, GOSY, VRML are active stocks in the news today.

MusclePharm Corporation (OTCBB: MSLP) reached up 41.50% in morning trading to $.0283 with 22M shares traded. MusclePharm is a healthy life-style company that develops and manufactures a full line of NSF International and Informed Choice approved nutritional supplements that are free of banned substances. Based on years of research at the MusclePharm Sports Science Center, the products are created through an advanced six-stage research protocol involving the expertise of top nutritional scientists and field tested by more than one hundred elite professional athletes from various professional sports leagues including the National Football League, Mixed Martial Arts and Major League Baseball. MusclePharm Corporation (OTCBB: MSLP.OB - News) today announced it has completed the retirement of all of its outstanding convertible notes held by various financing companies. 

GeckoSystems Intl. Corp. (PINK: GOSY) reached up 40% in morning trading to $.014 with 3M shares traded. GeckoSystems Intl. Corp. is a leading developer of mobile service robots (MSR's) based in metropolitan Atlanta, Georgia. Now entering their fourteenth year of business (Video & Pictorial History), the Company specializes in supplying mobile robot solutions for safety, security and service™. Their suite of MSR hardware and software (BaseBot™) technologies enable MSR's to automatically self-navigate the home or workplace using proprietary sense and avoid technologies for reliable, unattended collision avoidance while patrolling and/or seeking preset destinations. GeckoSystems Intl. Corp. (Pinksheets: GOSY.PK - News) announced today their progress regarding the Company's partnership with ZMP Inc. of Japan. GeckoSystems is a dynamic leader in the emerging mobile robotics industry revolutionizing their development and usage with "Mobile Robot Solutions for Safety, Security and Service™."

Vermillion, Inc. (NASDAQ: VRML) reached up 18.64% in morning trading to $2.10 with 2M shares traded. Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion, Inc. (NASDAQ: VRML - News) has received a notice of allowance from the United States Patent and Trademark Office for a patent, "Methods for Diagnosing Ovarian Cancer."

For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com

About PennyTrader.com
PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report.

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE